Pharvaris CFO sells 6,000 shares at $36.47

The report also records a 500-share gift to a charitable organization, separate from the 6,000-share sale.

Rhea-AI Filing Summary

Pharvaris N.V. (PHVS) CFO / CLO David W. Nassif reported selling 6,000 common shares on September 21, 2026, at a weighted average price of $36.4668 per share. The shares were sold in multiple transactions at prices ranging from $36.30 to $36.71 and had been acquired upon vesting of restricted stock units on various dates. Nassif also reported giving 500 common shares to a charitable organization on September 21, 2026. No Rule 10b5-1 plan is reported.

Insider Trade Summary

Net Seller: 6,000 shares

Net Sell 2 txns

Insider Nassif David W.

Role CFO / CLO

Sold 6,000 shs ($219K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	6,000	$36.4668	$219K
Gift	Common Stock F2	500	$0.00	$0.00

Holdings After Transaction: Common Stock — 113,800 shares (Direct)

Footnotes (2)

1. F1. The reported price represents a weighted average sale price for shares sold in multiple transactions at prices ranging from $36.30 to $36.71 per share. The shares sold were acquired upon vesting of restricted stock units on various dates. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
2. F2. Gift to charitable organization.

Key Figures

Common shares sold: 6,000 shares Weighted average sale price: $36.4668 per share Sale price range: $36.30 to $36.71 per share +1 more

4 metrics

Common shares sold 6,000 shares September 21, 2026

Weighted average sale price $36.4668 per share Sale reported for September 21, 2026

Sale price range $36.30 to $36.71 per share Multiple transactions for the shares sold

Common shares gifted 500 shares Gift to a charitable organization on September 21, 2026

Key Terms

weighted average sale price, restricted stock units, vesting

3 terms

weighted average sale price financial

"weighted average sale price for shares sold in multiple transactions"

restricted stock units financial

"acquired upon vesting of restricted stock units on various dates"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

vesting financial

"shares sold were acquired upon vesting of restricted stock units"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What PHVS shares did CFO / CLO David W. Nassif sell?

David W. Nassif reported selling 6,000 Pharvaris common shares on September 21, 2026, at a weighted average price of $36.4668 per share.

What was the PHVS sale price range?

The 6,000 shares were sold in multiple transactions at prices ranging from $36.30 to $36.71 per share. The reported weighted average sale price was $36.4668 per share.

Did the PHVS CFO / CLO also report a stock gift?

Yes. David W. Nassif reported a gift of 500 Pharvaris common shares to a charitable organization on September 21, 2026.

How did David W. Nassif acquire the shares he sold?

The shares sold were acquired upon vesting of restricted stock units on various dates.

Did the PHVS transaction report identify a Rule 10b5-1 plan?

No Rule 10b5-1 plan is reported.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/23/2026 - 10:06 AM Accepted by SEC EDGAR 09/23/2026 - 10:06 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nassif David W.

(Last) (First) (Middle)

1 CRANBERRY HILL SUITE 400

LEXINGTON

(Street)

LEXINGTON MASSACHUSETTS 02421

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Pharvaris N.V. [ PHVS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO / CLO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/21/2026		S		6,000	D	$36.4668(1)	114,300	D
Common Stock	09/21/2026		G(2)		500	D	$0	113,800	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported price represents a weighted average sale price for shares sold in multiple transactions at prices ranging from $36.30 to $36.71 per share. The shares sold were acquired upon vesting of restricted stock units on various dates. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

2. Gift to charitable organization.

	/s/ Marnus Nel, Attorney-in-Fact for David W. Nassif	09/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)